Researchers at the University of Edinburgh have identified a distinct hormonal pattern in people with endometriosis that could enable diagnosis through a simple blood test. This discovery offers hope for faster, less invasive detection of a condition that currently requires surgery to confirm.

Endometriosis affects roughly two million women in the UK, yet diagnosis typically demands laparoscopy, an invasive surgical procedure where doctors insert a camera into the abdomen. Patients often wait years for diagnosis while experiencing severe pelvic pain, infertility, and fatigue. The Edinburgh team's work changes this trajectory by identifying specific hormonal signatures that appear in those with the disease.

The research centers on how endometrial tissue grows outside the uterus, causing inflammation and scarring. The University of Edinburgh scientists found that this abnormal growth produces a recognizable hormonal pattern detectable in blood samples. By analyzing these patterns, clinicians could identify endometriosis without surgery.

Blood tests offer multiple advantages over current diagnostic methods. They spare patients from surgical risks, anesthesia complications, and recovery time. A positive blood test could prompt earlier treatment, reducing years of unmanaged symptoms. This is particularly important since endometriosis often goes undiagnosed for 7 to 10 years, during which pelvic pain worsens and fertility declines.

The test could also help clinicians monitor treatment effectiveness. Currently, doctors struggle to assess whether hormone therapies or surgical interventions work without repeat surgeries. A blood test would allow straightforward follow-up assessments.

While the Edinburgh findings represent progress, researchers caution that additional validation studies are needed before clinical implementation. The test must perform reliably across diverse patient populations and distinguish endometriosis from other pelvic conditions like fibroids or adenomyosis, which share similar symptoms.

The work aligns with broader efforts to improve endometriosis outcomes